Home medicines reviews: Extent of uptake by high-risk veterans

Journal of Pharmacy Practice and Research

Volumn 43, Issue 3, 2013, Pages 182-186

  Ellett, Lisa M Kalisch ^a   Ramsay, Emmae N ^a   Barratt, John D ^a   Gilbert, Andrew L ^a   Roughead, Elizabeth E ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FEMALE; HIGH RISK POPULATION; HOME CARE; HOME MEDICINE REVIEW; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PHARMACY; PRESCRIPTION; REVIEW; VETERAN;

EID: 84893362402     PISSN: 1445937X     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.2055-2335.2013.tb00250.x     Document Type: Review

References (23)

1. Department of Health and Ageing. Medicare benefits schedule book: operating from 1 January 2013. Canberra: The Department; 2012.
2. Roughead E, Barratt J, Ramsay E, Pratt N, Ryan P, Peck R, et al. The effectiveness of collaborative medicine reviews in delaying time to next hospitalisation for heart failure patients in the practice setting: results of a cohort study. Circ Heart Fail 2009; 2: 424-8.
3. Roughead E, Barratt J, Ramsay E, Pratt N, Ryan P, Peck R, et al. Collaborative home medicines review delays time to next hospitalisation for warfarin associated bleeding in Australian war veterans. J Clin Pharm Ther 2011; 36: 27-32.
4. March G, Gilbert A, Roughead E, Quintrell N. Developing and evaluating a model for pharmaceutical care in Australian community pharmacies. Int J Pharm Pract 1999; 7: 220-9.
5. Lee C, George J, Elliott R, Stewart K. Prevalence of medication-related risk factors among retirement village residents: a cross-sectional survey. Age Ageing 2010; 39: 581-7.
6. Roughead E, Pratt N, Peck R, Gilbert A. Improving medication safety: influence of a patient-specific prescriber feedback program on rate of medication reviews performed by Australian general medical practitioners. Pharmacoepidemiol Drug Saf 2007; 16: 797-803.
7. World Health Organization Collaborating Centre for Drug Statistics Methodology. Anatomical therapeutic chemical code classification index with defined daily doses. Oslo: World Health Organization; 2004.
8. Department of Health and Ageing. Schedule of pharmaceutical benefits. Canberra: The Department; 2009.
9. World Health Organization. International statistical classification of diseases and related health problems. Geneva: The Organization; 2002.
10. Australian Institute of Health and Welfare. Rural, regional and remote health. A guide to remoteness classifications. AIHW catalogue number PHE 53. Canberra: The Institute; 2004.
11. Australian Bureau of Statistics. Information paper: census of population and housing. Socio-economic indexes for areas, Australia, 2001. ABS cat. no. 2039.0. Canberra: The Bureau; 2003.
12. Sloan K, Sales A, Liu C, Fishman P, Nichol P, Suzuki N, et al. Construction and characteristics of the RxRisk-V: a VA-adapted pharmacy-based case-mix instrument. Med Care 2003; 41: 761-74.
13. Fishman P, Goodman M, Hornbrook M, Meenan R, Bachman D, O'Keefe Rosetti M. Risk adjustment using automated ambulatory pharmacy data: the RxRisk model. Med Care 2003; 41: 84-99.
14. Vitry A, Wong S, Roughead E, Ramsay E, Barratt J. Validity of medicationbased co-morbidity indices in the Australian elderly population. Aust N Z J Pub Health 2009; 33: 126-30.
15. Stafford A, Tenni P, Peterson G, Jackson S, Hejlesen A, Villesen C, et al. Drug-related problems identified in medication reviews by Australian pharmacists. Pharm World Sci 2009; 31: 216-23.
16. Campbell Research and Consulting. Home medicines review program qualitative research project final report. Canberra: Department of Health and Ageing, Medication Management and Research Section; 2008.
17. Lee C, George J, Elliott R, Stewart K. Exploring stakeholder perspectives on medication review services for older residents in retirement villages. Int J Pharm Pract 2012; 20: 249-58.
18. White L, Klinner C, Carter S. Consumer perspectives of the Australian home medicines review program: benefits and barriers. Res Social Adm Pharm 2012; 8: 4-16.
19. Carter S, Chen T, White L. Home medicines reviews: a quantitative study of the views of recipients and eligible non-recipients. Int J Pharm Pract 2012; 20: 209-17.
20. Stafford L, Peterson G, Bereznicki L, Jackson S, van Tienen E, Angley M, et al. Clinical outcomes of a collaborative, home-based postdischarge warfarin management service. Ann Pharmacother 2011; 45: 325-34.
21. Castelino R, Bajorek B, Chen T. Retrospective evaluation of home medicines review by pharmacists in older Australian patients using the medication appropriateness index. Ann Pharmacother 2010; 44: 1922-9.
22. Castelino R, Hilmer S, Bajorek B, Nishtala P, Chen T. Drug burden index and potentially inappropriate medications in community-dwelling older people: the impact of home medicines review. Drugs Aging 2010; 27: 135-48.
23. Nishtala P, McLachlan A, Bell J, Chen T. A retrospective study of drugrelated problems in Australian aged care homes: medication reviews involving pharmacists and general practitioners. J Eval Clin Pract 2011; 17: 97-103.